Klacid

Clarithromycin, the active ingredient in Klacid, is a macrolide antibiotic presented as an intravenous solution for intravenous use. It treats a range of bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, skin and soft‑tissue infections, and is used in Helicobacter pylori eradication regimens.

GNH USA supplies Klacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Klacid is a macrolide antibiotic indicated for several bacterial infections.

Community‑acquired pneumonia: effective in treating infection caused by susceptible bacteria, improving respiratory symptoms. Acute bacterial sinusitis: reduces sinus inflammation and clears pathogenic organisms. Acute bacterial exacerbations of chronic bronchitis: helps resolve worsening cough and sputum production. Skin and soft‑tissue infections: combats a variety of Gram‑positive and some Gram‑negative skin infections. Helicobacter pylori eradication regimens: used in combination therapy to eliminate H. pylori infection.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools occurring during therapy. - Abdominal pain: cramping or discomfort in the abdomen. - Headache: transient mild headache.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - QT prolongation: cardiac rhythm disturbance that may lead to arrhythmia. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Clostridioides difficile‑associated diarrhea: severe colitis requiring treatment.

Before initiating therapy, consider the following precautions: - Assess renal and hepatic function: adjust therapy if impairment is present. - Monitor cardiac status: avoid in patients with known QT prolongation or arrhythmias. - Use with caution in patients with cardiac disease: increased risk of rhythm disturbances. - Avoid in individuals with known macrolide allergy: risk of hypersensitivity reactions. - Store at controlled room temperature: keep in the original container, protect from moisture and light.

Clarithromycin may interact with several medications.

Major Interactions (Avoid): - Cisapride and pimozide: risk of severe QT prolongation. - Simvastatin and other CYP3A4 substrates: increased plasma concentrations leading to toxicity. - Ergot alkaloids: heightened risk of ergotism.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, monitor INR. - Oral contraceptives: reduced efficacy, consider alternative contraception. - Digoxin: increased serum levels, monitor for toxicity.